Protein Polymer Technologies Completes License Agreement With Surgica Corporation

Protein Polymer Technologies, Inc. (OTC BB: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis today announced that it has entered into an exclusive, worldwide License Agreement with Surgica Corporation through which PPTI has acquired the rights to Surgica’s technology and products. This license arrangement is completed pursuant to the asset purchase option agreement between the two companies previously announced.

MORE ON THIS TOPIC